Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verastem

7.57
+0.60008.61%
Volume:1.16M
Turnover:8.56M
Market Cap:389.78M
PE:-2.07
High:7.69
Open:6.88
Low:6.82
Close:6.97
Loading ...

Verastem Shares Rise After Agreement to Sell Securities Worth Roughly $75 Million

MT Newswires Live
·
25 Apr

Verastem Announces $75M Private Placement Agreement

TIPRANKS
·
25 Apr

Verastem Oncology Announces $75 Million Private Placement

THOMSON REUTERS
·
25 Apr

Verastem Inc - Private Placement Expected to Close on April 28, 2025

THOMSON REUTERS
·
25 Apr

Verastem Inc - to Sell $24 Million in Common Stock at $7.00 per Share

THOMSON REUTERS
·
25 Apr

BRIEF-Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors

Reuters
·
24 Apr

Verastem announces U.S. IND clearance of VS-7375

TIPRANKS
·
24 Apr

Verastem Inc - Phase 1/2a Trial in U.S. to Start Mid-2025

THOMSON REUTERS
·
24 Apr

Verastem Oncology Announces U.S. Ind Clearance of VS-7375, Oral Kras G12d (on/off) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors

THOMSON REUTERS
·
24 Apr

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Zacks
·
16 Apr

Jefferies Initiates Verastem at Buy With $15 Price Target

MT Newswires Live
·
10 Apr

Verastem Initiated at Buy by Jefferies

Dow Jones
·
10 Apr

Verastem initiated with a Buy at Jefferies

TIPRANKS
·
10 Apr

U.S. RESEARCH ROUNDUP- Carnival, JLL, Microsoft

Reuters
·
10 Apr

Verastem Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $15

THOMSON REUTERS
·
10 Apr

Verastem price target lowered to $8 from $9 at Mizuho

TIPRANKS
·
09 Apr

Mizuho Securities Adjusts Verastem Price Target to $8 From $9, Maintains Outperform Rating

MT Newswires Live
·
08 Apr

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
07 Apr

Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025

Business Wire
·
26 Mar

Verastem Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
24 Mar